The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database-Reference-Cited by-同舟云学术

The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database

Published:2022-03-04 Issue:2 Volume:46 Page:75-80
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Kittipoom Teerajed¹,Tantiworawit Adisak¹^ORCID,Punnachet Teerachat¹,Hantrakun Nonthakorn¹,Piriyakhuntorn Pokpong¹,Rattanathammethee Thanawat¹^ORCID,Hantrakool Sasinee¹,Chai-Adisaksopha Chatree¹,Rattarittamrong Ekarat¹,Norasetthada Lalita¹,Fanhchaksai Kanda²,Charoenkwan Pimlak²^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Hematology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

2. Department of Pediatrics, Division of Hematology and Oncology, Chiang Mai University, Chiang Mai, Thailand

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,Genetics (clinical),Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2022.2072326

Reference25 articles.

1. Physiology and pathophysiology of iron in hemoglobin-associated diseases

2. Survival and Complications in Thalassemia

3. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

4. Iron-Chelating Therapies in a Transfusion-Dependent Thalassaemia Population in Thailand

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thalassemia Disorders: A Scoping Insight toward Management and Patient Care Prospects;Journal of Preventive, Diagnostic and Treatment Strategies in Medicine;2024-07